Search alternatives:
point decrease » point increase (Expand Search)
non decrease » note decreased (Expand Search), fold decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 nn » 10 nm (Expand Search), 10 ng (Expand Search), 10 ns (Expand Search)
point decrease » point increase (Expand Search)
non decrease » note decreased (Expand Search), fold decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 nn » 10 nm (Expand Search), 10 ng (Expand Search), 10 ns (Expand Search)
-
241
-
242
-
243
Profound loss of neprilysin accompanied by decreased levels of neuropeptides and increased CRP in ulcerative colitis
Published 2017“…Patients with UC had lower neuronal SP; however non-neuronal SP remained similar. UC patients had also lower neuronal and non-neuronal VIP levels. …”
-
244
-
245
-
246
-
247
-
248
-
249
-
250
Aged blood factors decrease cellular responses associated with delayed gingival wound repair
Published 2017“…<div><p>Aging is a gradual biological process characterized by a decrease in cell and organism functions. …”
-
251
-
252
Sarcopenia as an Independent Risk Factor for Decreased BMD in COPD Patients: Korean National Health and Nutrition Examination Surveys IV and V (2008-2011)
Published 2016“…The prevalences of osteopenia and osteoporosis were 60.8% and 22.0%, respectively, in the sarcopenia group and 45.6% and 13.3% in the non-sarcopenia group (both p < 0.001). After adjusting for multiple variables, the presence of sarcopenia associated with increased the risk of osteopenia, osteoporosis, and a low BMD (OR = 3.227, 95% CI = 2.125–4.899, p < 0.001, OR = 6.952, 95% CI = 3.418–14.139, p < 0.001, and OR = 3.495, 95% CI = 2.315–5.278, p < 0.001, respectively). …”
-
253
-
254
-
255
-
256
-
257
-
258
-
259
-
260
Blocking of MC1R, MC2R or MC5R causes a decrease in the enucleation ratio of erythrocytes.
Published 2015“…The enucleation ratio was decreased in the erythroblasts treated with anti-MC1R nAb, anti-MC2R nAb or anti-MC5R nAb. *, <i>P <</i> 0.0001, each point versus control. n = 3; error bars, s.e.m. …”